Objective Haematological and liver fibrotic markers could be appreciably utilized for effective
monitoring of Chronic Hepatitis B viral (HBV) infection, thereby increasing patient's treatment …

Hepatitis-B (HBV) is a viral disease cause liver damage, cirrhosis, fibrosis and
hepatocellular carcinoma. Present study attempted to elucidate the biochemical and …

Hepatitis B virus (HBV) is one of the major causes of morbidity and mortality worldwide. The
aim of this study was to determine the haematological and immunological parameters in …

The current study sought to assess the levels of alanine aminotransferase and immune-
hematological alterations as an adjunct marker in HBV management where viral load testing …

Introduction: In a resource-constrained situation where HBV DNA viral load testing may not
be available or be prohibitively expensive, the current study sought to assess the levels of …

Hepatitis B virus infection is a serious global public health challenge that affects more than
two billion people worldwide. This study aimed to evaluate the serological pattern of HBV …

Introduction: Worldwide, most people living with chronic HBV infection are in in low-and
middle-income countries. Most of the burden of disease from HBV infection comes from …

Aims: To evaluate Hepatitis B virus (HBV) infection treatment outcome using the levels of
white blood cells, haemoglobin, platelets counts and other red cell indices of HBV positive …

Hepatitis B virus (HBV) infection is a viral infection that affects the liver causing acute as well
as chronic disease worldwide. Poor diagnosis and prognostic factors remain one of crucial …

Introduction: Hepatitis B infection continues to be a serious global health problem with about
2 billion people infected worldwide, many of these in sub-Saharan Africa. Methods: Records …